Pulmonary thromboembolism: State-of-the-Art-Review

Journal of Veterinary Emergency and Critical Care

Volumn 19, Issue 1, 2009, Pages 30-52

  Goggs, Robert ^a   Benigni, Livia ^a   Fuentes, Virginia Luis ^a   Chan, Daniel L ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Angiography; CT; D dimers; PTE; Thromboelastography

Indexed keywords

ANIMALIA; FELIDAE;

ANTICOAGULANT AGENT;

ANIMAL; ANIMAL DISEASE; CAT; CAT DISEASE; DOG; DOG DISEASE; HUMAN; LUNG EMBOLISM; REVIEW;

ANIMALS; ANTICOAGULANTS; CAT DISEASES; CATS; DOG DISEASES; DOGS; HUMANS; PULMONARY EMBOLISM;

EID: 61449188301     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2009.00388.x     Document Type: Article

References (244)

1. Suter PF. Lower airway and pulmonary parenchymal diseases, In : Suter PF. ed. Thoracic Radiography: A Text Atlas of Thoracic Diseases of the Dog and Cat. Basel, Switzerland : Wettswil 1984, pp. 517 682.
2. Sedlmeier H, Dahme E. Pulmonary circulatory abnormalities, In : Dobberstein E, Pallaske G, Stunzi H. eds. Handbuch der Speziellen Pathologischen Anatomie der Haustiere, 3rd ed. Berlin : Paul Parey 1962, pp. 148 157.
3. Johnson LR, Lappin R, Baker DC. Pulmonary thromboembolism in 29 dogs: 1985-1995. J Vet Intern Med 1999 13 (4) : 338 345.
4. Norris CR, Griffey SM, Samii VF. Pulmonary thromboembolism in cats: 29 cases (1987-1997). J Am Vet Med Assoc 1999 215 (11) : 1650 1654.
5. Schermerhorn T, Pembleton-Corbett JR, Kornreich B. Pulmonary thromboembolism in cats. J Vet Intern Med 2004 18 (4) : 533 535.
6. Moser KM, Guisan M, Bartimmo EE, et al. In vivo and post mortem dissolution rates of pulmonary emboli and venous thrombi in the dog. Circulation 1973 48 (1) : 170 178.
7. Lang IM, Marsh JJ, Konopka RG, et al. Factors contributing to increased vascular fibrinolytic-activity in mongrel dogs. Circulation 1993 87 (6) : 1990 2000.
8. Palmer KG, King LG, Van Winkle TJ. Clinical manifestations and associated disease syndromes in dogs with cranial vena cava thrombosis: 17 cases (1989-1996). J Am Vet Med Assoc 1998 213 (2) : 220 224.
9. Van Winkle TJ, Bruce E. Thrombosis of the portal vein in eleven dogs. Vet Pathol 1993 30 (1) : 28 35.
10. Hargis AM, Stephens LC, Benjamin SA, et al. Relationship of hypothyroidism to diabetes mellitus, renal amyloidosis, and thrombosis in purebred beagles. Am J Vet Res 1981 42 (6) : 1077 1081.
11. Keith JC Jr., Rawlings CA, Schaub RG. Pulmonary thromboembolism during therapy of dirofilariasis with thiacetarsamide: modification with aspirin or prednisolone. Am J Vet Res 1983 44 (7) : 1278 1283.
12. LaRue MJ, Murtaugh RJ. Pulmonary thromboembolism in dogs - 47 cases (1986-1987). J Am Vet Med Assoc 1990 197 (10) : 1368 1372.
13. Burns MG, Kelly AB, Hornof WJ, et al. Pulmonary artery thrombosis in three dogs with hyperadrenocorticism. J Am Vet Med Assoc 1981 178 (4) : 388 393.
14. Hardie EM, Vaden SL, Spaulding K, et al. Splenic infarction in 16 dogs: a retrospective study. J Vet Intern Med 1995 9 (3) : 141 148.
15. Bunch SE, Metcalf MR, Crane SW, et al. Idiopathic pleural effusion and pulmonary thromboembolism in a dog with autoimmune hemolytic-anemia. J Am Vet Med Assoc 1989 195 (12) : 1748 1753.
16. Klein MK, Dow SW, Rosychuk RA. Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: ten cases (1982-1987). J Am Vet Med Assoc 1989 195 (2) : 246 250.
17. Di Bartola SP, Meuten DJ. Renal amyloidosis in 2 dogs presented for thromboembolic phenomena. J Am Anim Hosp Assoc 1980 16 (1) : 129 135.
18. Green RA, Kabel AL. Hypercoagulable state in three dogs with nephrotic syndrome: role of acquired antithrombin III deficiency. J Am Vet Med Assoc 1982 181 (9) : 914 917.
19. Slauson DO, Gribble DH. Thrombosis complicating renal amyloidosis in dogs. Vet Pathol 1971 8 (4) : 352 363.
20. Warren DF, Turner DM, Kelly JD. Post-operative pulmonary embolism in the dog. Aust Vet J 1970 46 (6) : 277 280.
21. Suter PF, Ettinger SJ. Miscellaneous diseases of the thorax, In : Ettinger SJ. ed. Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat, 1st ed. Philadelphia : WB Saunders Co 1975, pp. 807 822.
22. Virchow RLK. Cellular Pathology. 1859 special ed. London : John Churchill 1978, pp. 204 207.
23. Dalen JE. Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis. Chest 2002 122 (4) : 1440 1456.
24. Aird WC. Vascular bed-specific thrombosis. J Thromb Haemost 2007 5 (suppl 1) : 283 291.
25. Greengard JS, Eichinger S, Griffin JH, et al. Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg->Gln mutation in the gene for factor V. N Engl J Med 1994 331 (23) : 1559 1562.
26. Dantzker DR, Wagner PD, Tornabene VW, et al. Gas exchange after pulmonary thromboemoblization in dogs. Circ Res 1978 42 (1) : 92 103.
27. Levy SE, Simmons DH. Mechanism of arterial hypoxemia following pulmonary thromboembolism in dogs. J Appl Physiol 1975 39 (1) : 41 46.
28. 2 on airway smooth muscle following pulmonary vascular occlusion. J Appl Physiol 1970 28 (5) : 570 573.
29. Thomas D, Stein M, Tanabe G, et al. Mechanism of bronchoconstriction produced by thromboemboli in dogs. Am J Physiol 1964 206 (6) : 1207 1212.
30. Austin JH. Intrapulmonary airway narrowing after pulmonary thromboembolism in dogs. Partial control by the parasympathetic nervous system. Invest Radiol 1973 8 (5) : 315 321.
31. Giammona ST, Mandelbaum I, Foy J, et al. Effects of pulmonary artery ligation on pulmonary surfactant and pressure-volume characteristics of dog lung. Circ Res 1966 18 (6) : 683 691.
32. Chernick V, Hodson WA, Greenfield LJ. Effect of chronic pulmonary artery ligation on pulmonary mechanics and surfactant. J Appl Physiol 1966 21 (4) : 1315 1320.
33. Finley TH, Swensen EW, Clements JA, et al. Changes in mechanical properties, appearance and surface activity of extracts of one lung following occlusion of its pulmonary artery in the dog. Physiologist 1960 3 (1) : 56 72.
34. Dennis JS. The pathophysiologic sequelae of pulmonary thromboembolism. Comp Contin Educ Pract Vet 1991 13 (12) : 1811 1818.
35. Singer D, Hesser C, Pick R, et al. Diffuse bilateral pulmonary edema associated with unilobar miliary pulmonary embolization in the dog. Circ Res 1958 6 (1) : 4 9.
36. Malik AB, van der Zee H. Mechanism of pulmonary edema induced by microembolization in dogs. Circ Res 1978 42 (1) : 73 79.
37. Perlman MB, Johnson A, Jubiz W, et al. Lipoxygenase products induce neutrophil activation and increase endothelial permeability after thrombin-induced pulmonary microembolism. Circ Res 1989 64 (1) : 62 73.
38. Fluckiger MA, Gomez JA. Radiographic findings in dogs with spontaneous pulmonary thrombosis or embolism. Vet Radiol 1984 25 (3) : 124 131.
39. Dalen JE, Haffajee CI, Alpert JS, et al. Pulmonary-embolism, pulmonary hemorrhage and pulmonary infarction. N Engl J Med 1977 296 (25) : 1431 1435.
40. Ebert PA, Allgood RJ, Jones HW III., et al. Hemodynamics during pulmonary artery occlusion. Surgery 1967 62 (1) : 18 24.
41. West JB. Blood flow and metabolism, In : West JB. Respiratory Physiology: The Essentials, 7th ed. Philadelphia : Lippincott Williams & Wilkins 2005, pp. 35 54.
42. Halmagyi DF, Starzecki B, Horner GJ. Humoral transmission of cardiorespiratory changes in experimental lung embolism. Circ Res 1964 14 (6) : 546 554.
43. Gurewich V, Cohen ML, Thomas DP. Humoral factors in massive pulmonary embolism: an experimental study. Am Heart J 1968 76 (6) : 784 794.
44. McGoon MD, Vanhoutte PM. Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine. J Clin Invest 1984 74 (3) : 828 833.
45. Snyder LA, Neel JA, Grindem CB. Thrombocytosis in dogs: a retrospective study. Vet Clin Pathol 2007 36 (3) : 315.
46. Feldman BF. Thrombosis - diagnosis and treatment, In : Kirk RW. ed. Current Veterinary Therapy IX: Small Animal Practice, 9th ed. Philadelphia : WB Saunders Co. 1986, pp. 505 509.
47. Schafer AI. Thrombocytosis. N Engl J Med 2004 350 (12) : 1211 1219.
48. Feldman BF, Kirby R, Caldin M. Recognition and treatment of disseminated intravascular coagulation, In : Bonagura JD. ed. Kirk's Current Veterinary Therapy XIII: Small Animal Practice, 13th ed. Philadelphia : WB Saunders Co. 2000, pp. 190 194.
49. Maloba M, Hogg K. Best evidence topic report. Diagnostic utility of arterial blood gases for investigation of pulmonary embolus. Emerg Med J 2005 22 (6) : 435 436.
50. Cloutier LM. Diagnosis of pulmonary embolism. Clin J Oncol Nurs 2007 11 (3) : 343 348.
51. Riedel M. Diagnosing pulmonary embolism. Postgrad Med J 2004 80 (944) : 309 319.
52. McIntyre KM, Sasahara AA. The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol 1971 28 (2) : 288 294.
53. Hsu JT, Chu CM, Chang ST, et al. Prognostic role of alveolar-arterial oxygen pressure difference in acute pulmonary embolism. Circ J 2006 70 (12) : 1611 1616.
54. Hsu JT, Chu CM, Chang ST, et al. Prognostic value of arterial/alveolar oxygen tension ratio (a/APO2) in acute pulmonary embolism. Circ J 2007 71 (10) : 1560 1566.
55. Westermark N. On the roentgen diagnosis of lung embolism. Acta Radiol 1938 19 : 357 372.
56. Dennis JS. Clinical features of canine pulmonary thromboembolism. Compendium Continuing Vet Ed 1993 15 (12) : 1595 1603.
57. Figley MM, Gerdes AJ, Ricketts HJ. Radiographic aspects of pulmonary embolism. Semin Roentgenol 1967 2 (4) : 389 405.
58. Keyes ML, Rush JE, Knowles KE. Pulmonary thromboembolism in dogs. J Vet Emerg Crit Care 1993 3 (1) : 23 32.
59. Hackner SG. Pulmonary thromboembolism, In : King LG. ed. Textbook of Respiratory Disease in Dogs and Cats. Philadelphia : WB Saunders Co 2004, pp. 526 541.
60. Roemisch J, Gray E, Hoffmann JN, et al. Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul Fibrinolysis 2002 13 (8) : 657 670.
61. Bick RL. Clinical relevance of antithrombin III. Semin Thromb Hemost 1982 8 (4) : 276 287.
62. Green RA. Pathophysiology of antithrombin III deficiency. Vet Clin North Am Small Anim Pract 1988 18 (1) : 95 104.
63. Nelson OL, Andreasen C. The utility of plasma D-dimer to identify thromboembolic disease in dogs. J Vet Intern Med 2003 17 (6) : 830 834.
64. Stokol T. Plasma D-dimer for the diagnosis of thromboembolic disorders in dogs. Vet Clin North Am Small Anim Pract 2003 33 (6) : 1419 1435.
65. Scott-Moncrieff JC, Treadwell NG, McCullough SM, et al. Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia. J Am Anim Hosp Assoc 2001 37 (3) : 220 227.
66. Boisvert AM, Swenson CL, Haines CJ. Serum and plasma latex agglutination tests for detection of fibrin(ogen) degradation products in clinically ill dogs. Vet Clin Pathol 2001 30 (3) : 133 136.
67. Stokol T, Brooks MB, Erb HN, et al. D-dimer concentrations in healthy dogs and dogs with disseminated intravascular coagulation. Am J Vet Res 2000 61 (4) : 393 398.
68. Stein PD, Woodard PK, Weg JG, et al. Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators. Radiology 2007 242 (1) : 15 21.
69. Griffin A, Callan MB, Shofer FS, et al. Evaluation of a canine D-dimer point-of-care test kit for use in samples obtained from dogs with disseminated intravascular coagulation, thromboembolic disease, and hemorrhage. Am J Vet Res 2003 64 (12) : 1562 1569.
70. Ben S, Ni S, Shen H, et al. The dynamic changes of LDH isoenzyme 3 and D-dimer following pulmonary thromboembolism in canine. Thromb Res 2007 120 (4) : 575 583.
71. Callan MB, Aljamali MN, Margaritis P, et al. A novel missense mutation responsible for factor VII deficiency in research Beagle colonies. J Thromb Haemost 2006 4 (12) : 2616 2622.
72. Donahue SM, Otto CM. Thromboelastography: a tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis. J Vet Emerg Crit Care 2005 15 (1) : 9 16.
73. Brainard BM, Meredith CP, Callan MB, et al. Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs. Am J Vet Res 2007 68 (3) : 251 257.
74. Varon D, Savion N. Impact cone and plate(let) analyzer, In : Michelson AD. ed. Platelets. Amsterdam: Elsevier 2007, pp. 535 544.
75. Hartert H. Blutgerinnungsstudien mit der thrombelastographie, einem neuen untersuchungsverfahren. Klinische Wochenschrift 1948 26 (37-38) : 577 583.
76. Kang Y, Marquez D, Lewis J, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985 64 (9) : 888 896.
77. Shore-Lesserson L, Manspeizer H, De Perio M, et al. Thromboelastography- guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999 88 (2) : 312 319.
78. Sorensen B, Ingerslev J. Whole blood clot formation phenotypes in haemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haem 2004 2 (1) : 102 110.
79. Handa A, Cox D, Hamilton G, Pasi K, et al. Thrombelastography: an effective screening test for prothrombotic states. Thromb Haem 1997 78 (S1) : 440.
80. O'Donnell J, Riddell A, Owens D, et al. Role of the thrombelastograph as an adjunctive test in thrombophilia screening. Blood Coag Fibrinol 2004 15 (3) : 207 211.
81. Steib A, Gengenwin N, Freys G, et al. Predictive factors of hyperfibrinolytic activity during liver transplantation in cirrhotic patients. Br J Anaesth 1994 73 (5) : 645 648.
82. Wiinberg B, Jensen AL, Rojkjaer R, et al. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol 2005 34 (4) : 389 393.
83. Alwood AJ, Downend AB, Brooks MB, et al. Anticoagulant effects of low-molecular-weight heparins in healthy cats. J Vet Intern Med 2007 21 (3) : 378 387.
84. Montgomery A, Couto CG, Schober K, et al. Thromboelastography in healthy cats. J Vet Intern Med 2008 22 (3) : 774.
85. Bjornvad CR, Wiinberg B, Jensen AL, et al. Evaluation of tissue factor and kaolin activated thromboelastography on feline citrated whole blood from clinically healthy cats. J Vet Intern Med 2008 22 (3) : 739.
86. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005 27 (2) : 81 90.
87. Nielsen VG. A comparison of the thrombelastograph and the ROTEM. Blood Coagul Fibrinolysis 2007 18 (3) : 247 252.
88. Alwood AJ, Downend AB, Slensky KA, et al. Evaluation of thromboelastography (TEG) in normal cats. J Vet Emerg Crit Care 2004 14 (S1) : S1.
89. McCrath DJ, Cerboni E, Frumento RJ, et al. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005 100 (6) : 1576 1583.
90. Otto CM, Rieser TM, Brooks MB, et al. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000 217 (10) : 1500 1504.
91. Kristensen AT, Wiinberg B, Jessen LR, et al. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med 2008 22 (1) : 140 147.
92. Wiinberg B, Jensen AL, Johansson PI, et al. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med 2008 22 (2) : 357 365.
93. Dalen JE, Mathur VS, Evans H, et al. Pulmonary angiography in experimental pulmonary embolism. Am Heart J 1966 72 (4) : 509 520.
94. Bookstein JJ, Silver TM. The angiographic differential diagnosis of acute pulmonary embolism. Radiology 1974 110 (1) : 25 33.
95. Henderson RA, Dillon AR, Brawner WR, et al. Technique for percutaneous pulmonary arterial catheterization in conscious dogs. Am J Vet Res 1985 46 (7) : 1538 1539.
96. Newman GE. Pulmonary angiography in pulmonary embolic disease. J Thorac Imag 1989 4 (4) : 28 39.
97. Cornelissen JMM, Wolvekamp WTC, Stokhof AA, et al. Primary occlusive pulmonary vascular-disease in a dog diagnosed by a lung perfusion scintigram. J Am Anim Hosp Assoc 1985 21 (2) : 293 299.
98. Miller MS, Tilley LP, Calvert CA. Electrocardiographic correlations in pulmonary heart disease. Semin Vet Med Surg (Small Anim) 1986 1 (4) : 331 337.
99. Goldhaber SZ. Echocardiography in the management of pulmonary embolism. Ann Int Med 2002 136 (9) : 691 700.
100. Nazeyrollas P, Metz D, Chapoutot L, et al. Diagnostic accuracy of echocardiography-Doppler in acute pulmonary embolism. Int J Cardiol 1995 47 (3) : 273 280.
101. Kasper W, Meinertz T, Henkel B, et al. Echocardiographic findings in patients with proved pulmonary-embolism. Am Heart J 1986 112 (6) : 1284 1290.
102. Ribeiro A, Lindmarker P, JuhlinDannfelt A, et al. Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J 1997 134 (3) : 479 487.
103. Goldhaber SZ, Visani L, De Rosa M, et al. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999 353 (9162) : 1386 1389.
104. Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997 30 (5) : 1165 1171.
105. Torbicki A, van Beek EJR, Charbonnier B, et al. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 2000 21 (16) : 1301 1336.
106. Ribeiro A, Juhlin-Dannfelt A, Brodin LA, et al. Pulmonary embolism: relation between the degree of right ventricle overload and the extent of perfusion defects. Am Heart J 1998 135 (5) : 868 874.
107. McConnell MV, Solomon SD, Rayan ME, et al. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 1996 78 (4) : 469 473.
108. Chetboul V, Sampedrano CC, Gouni V, et al. Ultrasonographic assessment of regional radial and longitudinal systolic function in healthy awake dogs. J Vet Intern Med 2006 20 (4) : 885 893.
109. Venco L, Calzolari D, Morini S. Pulmonary thromboembolism in a dog with renal amyloidosis. Vet Radiol Ultrasound 1998 39 (6) : 564 565.
110. Schober KE. Biochemical markers of cardiovascular disease, In : Ettinger SJ, Feldman EC. eds. Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat, 6th ed. Philadelphia : Elsevier Saunders 2005, pp. 940 948.
111. Ricchiuti V, Sharkey SW, Murakami MM, et al. Cardiac troponin I and T alterations in dog hearts with myocardial infarction: correlation with infarct size. Am J Clin Pathol 1998 110 (2) : 241 247.
112. Schober KE, Cornand C, Kirbach B, et al. Serum cardiac troponin I and cardiac troponin T concentrations in dogs with gastric dilatation-volvulus. J Am Vet Med Assoc 2002 221 (3) : 381 388.
113. Lobetti R, Dvir E, Pearson J. Cardiac troponins in canine babesiosis. J Vet Intern Med 2002 16 (1) : 63 68.
114. Janata K, Holzer M, Laggner AN, et al. Cardiac troponin T in the severity assessment of patients with pulmonary embolism: cohort study. Br Med J 2003 326 (7384) : 312 313.
115. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism - a meta-analysis. Circulation 2007 116 (4) : 427 433.
116. Alderson PO, Doppman JL, Diamond SS, et al. Ventilation-perfusion lung imaging and selective pulmonary angiography in dogs with experimental pulmonary embolism. J Nucl Med 1978 19 (2) : 164 171.
117. Koblik PD, Hornof W, Harnagel SH, et al. A comparison of pulmonary angiography, digital subtraction angiography, and 99mTc-DTPA/MAA ventilation-perfusion scintigraphy for detection of experimental pulmonary emboli in the dog. Vet Radiol 1989 30 (4) : 159 168.
118. Pouchelon JL, Chetboul V, Devauchelle P, et al. Diagnosis of pulmonary thromboembolism in a cat using echocardiography and pulmonary scintigraphy. J Small Anim Pract 1997 38 (7) : 306 310.
119. Daniel GB, Berry CR. Pulmonary and mucociliary scintigraphy, In : Berry CR, Daniel GB. eds. Textbook of Veterinary Nuclear Medicine, 2nd ed. Harrisburg, PA : American College of Veterinary Radiology 2006, pp. 304 327.
120. Remy-Jardin M, Remy J, Wattinne L, et al. Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single-breath-hold technique-comparison with pulmonary angiography. Radiology 1992 185 (2) : 381 387.
121. Gurney JW. No fooling around: direct visualization of pulmonary embolism. Radiology 1993 188 (3) : 618 619.
122. Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 2006 354 (22) : 2317 2327.
123. Sinner WN. Computed tomographic patterns of pulmonary thromboembolism and infarction. J Comput Assist Tomogr 1978 2 (4) : 395 399.
124. Goodman LR, Curtin JJ, Mewissen MW, et al. Detection of pulmonary embolism in patients with unresolved clinical and scintigraphic diagnosis: helical CT versus angiography. Am J Roentgenol 1995 164 (6) : 1369 1374.
125. Rathbun SW, Raskob GE, Whitsett TL. Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review. Ann Intern Med 2000 132 (3) : 227 232.
126. Mullins MD, Becker DM, Hagspiel KD, et al. The role of spiral volumetric computed tomography in the diagnosis of pulmonary embolism. Arch Intern Med 2000 160 (3) : 293 298.
127. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). J Am Med Assoc 1990 263 (20) : 2753 2759.
128. American College of Emergency Physicians Clinical Policies Committee; Clinical Policies Committee Subcommittee on Suspected Pulmonary Embolism. Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected pulmonary embolism. Ann Emerg Med 2003 41 (2) : 257 270.
129. British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group. Thorax 2003 58 (6) : 470 483.
130. Schoepf UJ, Costello P. CT angiography for diagnosis of pulmonary embolism: state of the art. Radiology 2004 230 (2) : 329 337.
131. Quiroz R, Kucher N, Zou KH, et al. Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review. J Am Med Assoc 2005 293 (16) : 2012 2017.
132. Perrier A, Roy PM, Sanchez O, et al. Multidetector-row computed tomography in suspected pulmonary embolism. N Engl J Med 2005 352 (17) : 1760 1768.
133. Frank P, Mahaffey M, Egger C, et al. Helical computed tomographic portography in ten normal dogs and ten dogs with a portosystemic shunt. Vet Radiol Ultrasound 2003 44 (4) : 392 400.
134. Zwingenberger AL, Schwarz T. Dual-phase CT angiography of the normal canine portal and hepatic vasculature. Vet Radiol Ultrasound 2004 45 (2) : 117 124.
135. Zwingenberger AL, Schwarz T, Saunders HM. Helical computed tomographic angiography of canine portosystemic shunts. Vet Radiol Ultrasound 2005 46 (1) : 27 32.
136. Tidwell SA, Graham JP, Peck JN, et al. Incidence of pulmonary embolism after non-cemented total hip arthroplasty in eleven dogs: computed tomographic pulmonary angiography and pulmonary perfusion scintigraphy. Vet Surg 2007 36 (1) : 37 42.
137. Kirberger RM, Zambelli A. Imaging diagnosis - aortic thromboembolism associated with spirocercosis in a dog. Vet Radiol Ultrasound 2007 48 (5) : 418 420.
138. van Beek EJ, Wild JM, Fink C, et al. MRI for the diagnosis of pulmonary embolism. J Magn Reson Imaging 2003 18 (6) : 627 640.
139. Hurst DR, Kazerooni EA, Stafford-Johnson D, et al. Diagnosis of pulmonary embolism: comparison of CT angiography and MR angiography in canines. J Vasc Interv Radiol 1999 10 (3) : 309 318.
140. Moody AR, Liddicoat A, Krarup K. Magnetic resonance pulmonary angiography and direct imaging of embolus for the detection of pulmonary emboli. Invest Radiol 1997 32 (8) : 431 440.
141. Morris TA, Marsh JJ, Chiles PG, et al. Single photon emission computed tomography of pulmonary emboli and venous thrombi using anti-D-dimer. Am J Respir Crit Care Med 2004 169 (9) : 987 993.
142. Sanson BJ, Lijmer JG, Mac Gillavry MR, et al. Comparison of a clinical probability estimate and two clinical models in patients with suspected pulmonary embolism. ANTELOPE-Study Group. Thromb Haemost 2000 83 (2) : 199 203.
143. Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000 83 (3) : 416 420.
144. Chagnon I, Bounameaux H, Aujesky D, et al. Comparison of two clinical prediction rules and implicit assessment among patients with suspected pulmonary embolism. Am J Med 2002 113 (4) : 269 275.
145. Nelson OL. Use of the D-dimer assay for diagnosing thromboembolic disease in the dog. J Am Anim Hosp Assoc 2005 41 (3) : 145 149.
146. Goldhaber SZ. Deep vein thrombosis and pulmonary embolism, In : Kitchens CS, Alving BM, Kessler CM. eds. Consultative Hemostasis and Thrombosis, 2nd ed. Philadelphia : WB Saunders Co 2007, pp. 245 256.
147. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992 326 (19) : 1240 1245.
148. Thorpe PE. The role of thrombolytic therapy in pulmonary embolism. Tech Vasc Interv Radiol 1998 1 (4) : 199 208.
149. Carlbom DJ, Davidson BL. Pulmonary embolism in the critically ill. Chest 2007 132 (1) : 313 324.
150. Hirsch LJ, Rooney MW, Wat SS, et al. Norepinephrine and phenylephrine effects on right ventricular function in experimental canine pulmonary embolism. Chest 1991 100 (3) : 796 801.
151. Pascoe PJ, Ilkiw JE, Pypendop BH. Effects of increasing infusion rates of dopamine, dobutamine, epinephrine, and phenylephrine in healthy anesthetized cats. Am J Vet Res 2006 67 (9) : 1491 1499.
152. Hofmeister EH, Keenan K, Egger CM. Dobutamine-induced bradycardia in a dog. Vet Anaesthesia Analgesia 2005 32 (2) : 107 111.
153. Tanus-Santos JE, Theodorakis MJ. Is there a place for inhaled nitric oxide in the therapy of acute pulmonary embolism? Am J Respir Med 2002 1 (3) : 167 176.
154. Griffiths MJ, Evans TW. Inhaled nitric oxide therapy in adults. N Engl J Med 2005 353 (25) : 2683 2695.
155. Bach JF, Rozanski EA, MacGregor J, et al. Retrospective evaluation of sildenafil citrate as a therapy for pulmonary hypertension in dogs. J Vet Intern Med 2006 20 (5) : 1132 1135.
156. Kellum HB, Stepien RL. Sildenafil citrate therapy in 22 dogs with pulmonary hypertension. J Vet Intern Med 2007 21 (6) : 1258 1264.
157. Dias-Junior CA, Souza-Costa DC, Zerbini T, et al. The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension. Anesth Analg 2005 101 (1) : 115 120.
158. Dias-Junior CA, Vieira TF, Moreno H Jr., et al. Sildenafil selectively inhibits acute pulmonary embolism-induced pulmonary hypertension. Pulm Pharmacol Ther 2005 18 (3) : 181 186.
159. Souza-Silva AR, Dias-Junior CA, Uzuelli JA, et al. Hemodynamic effects of combined sildenafil and l-arginine during acute pulmonary embolism-induced pulmonary hypertension. Eur J Pharmacol 2005 524 (1-3) : 126 131.
160. Dias-Junior CA, Tanus-Santos JE. Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism. Life Sci 2006 79 (5) : 469 474.
161. Ganiere V, Feihl F, Tagan D. Dramatic beneficial effects of sildenafil in recurrent massive pulmonary embolism. Intensive Care Med 2006 32 (3) : 452 454.
162. Bresser P, Pepke-Zaba J, Jaïs X, et al. Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm. Proc Am Thorac Soc 2006 3 (7) : 594 600.
163. Patel SC, Mody A Cerebral hemorrhagic complications of thrombolytic therapy. Prog Cardiovas Dis 1999 42 (3) : 217 233.
164. Vanscoy GJ, Rihn TL, Koerner PH. Tenecteplase: innovative fibrinolysis for ST segment elevation myocardial infarction (STEMI). Pharm Ther 2003 28 (1) : 20 30.
165. Arcasoy SM, Kreit JW Thrombolytic therapy of pulmonary embolism. Chest 1999 115 (6) : 1695 1707.
166. Moore KE, Morris N, Dhupa N, et al. Retrospective study of streptokinase administration in 46 cats with arterial thromboembolism. J Vet Emerg Crit Care 2000 10 (4) : 245 257.
167. Pion PD. Feline aortic thromboemboli and the potential utility of thrombolytic therapy with tissue plasminogen activator. Vet Clin North Am Small Anim Pract 1988 18 (1) : 79 86.
168. Ramsey CC, Burney DP, Macintire DK, et al. Use of streptokinase in four dogs with thrombosis. J Am Vet Med Assoc 1996 209 (4) : 780 785.
169. Whelan MF, O'Toole TE. The use of thrombolytic agents. Comp Contin Edu Prac Vet 2007 29 (8) : 476 482.
170. Marjerus PW, Broze GJ Jr., Miletich JP, et al. Anticoagulant, thrombolytic, and antiplatelet drugs, In : Hardman JG, Limbird LE, Molinoff PB, et al., eds. Goodman and Gilman's the Pharmacologic Basis of Therapeutics, 9th ed. New York : McGraw-Hill 1996, pp. 1341 1359.
171. Whelan MF, O'Toole TE, Chan DL, et al. Retrospective evaluation of urokinase use in cats with arterial thromboembolism. J Vet Emerg Crit Care 2005 15 (S1) : S8.
172. Haberstroh J, Wagner G, Kiefer T, et al. Renal artery occlusion model in dogs for the evaluation of thrombolytic agents. J Invest Surg 1997 10 (4) : 183 188.
173. Maki A, Shirato C, Ohguchi M, Aoki N, et al. Mechanism of rethrombosis after thrombolytic therapy: angioscopic findings and investigation of the coagulation system in dogs. Angiology 1998 49 (6) : 447 453.
174. Rhodes JM, Cho JS, Gloviczki P, et al. Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity. J Vasc Surg 2000 31 (6) : 1193 1205.
175. Whelan MF, O'Toole TE, Chan DL, et al. Retrospective evaluation of urokinase use in dogs with thromboembolism (4 cases): 2003-2004). J Vet Emerg Crit Care 2005 15 (S1) : S8.
176. Marder VJ. Thrombolytic therapy, In : Kitchens CS, Alving BM, Kessler CM. eds. Consultative Hemostasis and Thrombosis, 2nd ed. Philadelphia : WB Saunders Co 2007, pp. 491 502.
177. Longstaff C, Thelwell C. Understanding the enzymology of fibrinolysis and improving thrombolytic therapy. FEBS Lett 2005 579 (15) : 3303 3309.
178. Clare AC, Kraje BJ. Use of recombinant tissue-plasminogen activator for aortic thrombolysis in a hypoproteinemic dog. J Am Vet Med Assoc 1998 212 (4) : 539 543.
179. Shiffman F, Ducas J, Hollett P, et al. Treatment of canine pulmonary hypertension with recombinant tissue plasminogen activator. Circulation 1988 78 (1) : 214 220.
180. Lunsford KV, Mackin AJ. Thromboembolic therapies in dogs and cats: an evidence-based approach. Vet Clin Small Anim 2007 37 (3) : 579 609.
181. Buller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 126 (3, suppl) : 401S 428S.
182. Kucher N, Rossi E, De Rosa M, et al. Massive pulmonary embolism. Circulation 2006 113 (4) : 577 582.
183. Morris TA, Marsh JJ, Chiles PG, et al. Embolization itself stimulates thrombus propagation in pulmonary embolism. Am J Physiol Heart Circ Physiol 2004 287 (2) : H818 H822.
184. Watson HG, Chee YL. Aspirin and other antiplatelet drugs in the prevention of venous thromboembolism. Blood Rev 2008 22 (2) : 107 116.
185. Hurlen M, Abdelnoor M, Smith P, et al. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 2002 347 (13) : 969 974.
186. Schulman S, Lindmarker P, Holmstrom M, et al. Postthrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost 2006 4 (4) : 734 742.
187. Buller HR, Davidson BL, Decousus H, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003 349 (18) : 1695 1702.
188. Eriksson UG, Bredberg U, Hoffmann KJ, et al. Absorption, distribution, metabolism, and excretion of ximelagatran an oral direct thrombin inhibitor, in rats, dogs, and humans. Drug Metab Disp 2003 31 (3) : 294 305.
189. Mattson C, Bjorkman JA, Abrahamsson T, et al. Local proCPU (TAFI) activation during thrombolytic treatment in a dog model of coronary artery thrombosis can be inhibited with a direct, small molecule thrombin inhibitor (melagatran). Thromb Haemost 2002 87 (4) : 557 562.
190. Hirsh J, Raschke R. Heparin and low molecular weight heparins: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 126 (3, suppl) : 188S 203S.
191. Casu B, Oreste P, Torri G, et al. The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Biochem J 1981 197 (3) : 599 609.
192. Ofosu FA, Hirsh J, Esmon CT, et al. Unfractionated heparin inhibits thrombin-catalyzed amplification reactions of coagulation more efficiently than those catalyzed by factor Xa. Biochem J 1989 257 (1) : 143 150.
193. Ofosu FA, Sie P, Modi GJ, et al. The inhibition of thrombin-dependent feedback reactions is critical to the expression of anticoagulant effects of heparin. Biochem J 1987 243 (2) : 579 588.
194. Beguin S, Lindhout T, Hemker HC. The mode of action of heparin in plasma. Thromb Haemost 1988 60 (3) : 457 462.
195. Mischke RH, Schuttert C, Grebe SI. Anticoagulant effects of repeated subcutaneous injections of high doses of unfractionated heparin in healthy dogs. Am J Vet Res 2001 62 (12) : 1887 1891.
196. Green RA. Activated partial thromboplastin time in monitoring heparinized dogs. Am J Vet Res 1980 11 : 1793 1797.
197. Hellebrekers LJ, Slappendel RJ, van den Brom WE. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog. Am J Vet Res 1985 46 : 1460 1462.
198. Raschke RA, Reilly BM, Guidry JR, et al. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial. Ann Intern Med 1993 119 (9) : 874 881.
199. Harenberg J. Pharmacology of low molecular weight heparins. Semin Thromb Hemost 1990 16 (suppl) : 12 18.
200. Handeland GF, Abildgaard GF, Holm U, et al. Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin. Eur J Clin Pharmacol 1990 39 (2) : 107 112.
201. Lunsford K, Mackin A, Langston VC, et al. Pharmacokinetics of the biological effects of subcutaneously administered enoxaparin, a low molecular weight heparin, in dogs. J Vet Intern Med 2005 19 (3) : 401.
202. Mischke R, Grebe S, Jacobs C, et al. Amidolytic heparin activity and values for several hemostatic variables after repeated subcutaneous administration of high doses of a low molecular weight heparin in healthy dogs. Am J Vet Res 2001 62 (4) : 595 598.
203. Grebe S, Jacobs C, Kietzmann M, et al. Pharmacokinetics of low-molecular-weight heparins Fragmin D in dogs. Berl Munch Tierarztl Wochenschr 2000 113 (3) : 103 107.
204. Bauer KA, Hawkins DW, Peters PC, et al. Fondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents - the selective factor Xa inhibitors. Cardiovasc Drug Rev 2002 20 (1) : 37 52.
205. Ansell J, Hirsh J, Poller L, et al. The pharmacology and management of vitamin K antagonists: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004 126 (3, suppl) : 204S 233S.
206. Hirsh J, O'Donnell M, Eikelboom JW. Beyond unfractionated heparin and warfarin: current and future advances. Circulation 2007 116 (5) : 552 560.
207. Turpie AG. New oral anticoagulants in atrial fibrillation. Eur Heart J 2007 29 (2) : 155 165.
208. Bauer KA. New anticoagulants. Hematology Am Soc Hematol Educ Program 2006 1 : 450 456.
209. Fasco MJ, Hildebrandt EF, Suttie JW. Evidence that warfarin anticoagulant action involves two distinct reductase activities. J Biol Chem 1982 257 (19) : 11210 11212.
210. Nelsestuen GL, Zytkovicz TH, Howard JB. The mode of action of vitamin K: identification of γ-carboxyglutamic acid as a component of prothrombin. J Biol Chem 1974 249 (19) : 6347 6350.
211. Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001 119 (suppl) : 8S 21S.
212. Nelsestuen GL. Role of gamma-carboxyglutamic acid: an unusual transition required for calcium-dependent binding of prothrombin to phospholipid. J Biol Chem 1976 251 (18) : 5648 5656.
213. Borowski M, Furie BC, Bauminger S, et al. Prothrombin requires two sequential metal-dependent conformational transitions to bind phospholipid. J Biol Chem 1986 261 (32) : 14969 14975.
214. Kirkwood TB. Calibration of reference thromboplastins and standardisation of the prothrombin time ratio. Thromb Haemost 1983 49 (3) : 238 244.
215. Monnet E, Morgan MR. Effect of three loading doses of warfarin on the international normalized ratio for dogs. Am J Vet Res 2000 61 (1) : 48 50.
216. Smith SA. Warfarin treatment in small animal patients [abstract]. Proceedings of the 16th Annual ACVIM Forum, American College of Veterinary Internal Medicine, San Diego, 1998. p. 440.
217. Orton EC, Hackett TB, Mama K, et al. Technique and outcome of mitral valve replacement in dogs. J Am Vet Med Assoc 2005 226 (9) : 1508 1511.
218. Hoffman M, Monroe DM III. A cell-based model of hemostasis. Thromb Haemost 2001 85 (6) : 958 965.
219. Hogan DF, Andrews DA, Talbott KK, et al. Evaluation of antiplatelet effects of ticlopidine in cats. Am J Vet Res 2004 65 (3) : 327 332.
220. Weinkle TK, Center SA, Randolph JF, et al. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002). J Am Vet Med Assoc 2005 226 (11) : 1869 1880.
221. Hogan DF. Interim analysis from the fat cat study on arterial thromboembolism. Proceedings ACVIM 25th Annual Forum, Seattle, WA, 2007.
222. Bright JM, Dowers K, Powers BE. Effects of the glycoprotein IIb/IIIa antagonist abciximab on thrombus formation and platelet function in cats with arterial injury. Vet Ther 2003 4 (1) : 35 46.
223. Bright JM, Dowers K, Hellyer P. In vitro antiaggregatory effects of GP IIb/IIIa antagonist eptifibatide on feline platelets. J Vet Intern Med 2002 6 : 16:v (letter).
224. Hylands R. Veterinary diagnostic imaging. Can Vet J 2006 47 (4) : 385 388.
225. Cipollone F, Patrignani P, Greco A, et al. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation 1997 96 (4) : 1109 1116.
226. Preston FE, Whipps S, Jackson CA, et al. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. N Engl J Med 1981 304 (2) : 76 79.
227. Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest 1982 69 (6) : 1366 1372.
228. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994 330 (18) : 1287 1294.
229. Smith SA, Tobias AH, Jacob KA, et al. Arterial thromboembolism in cats: acute crisis in 127 cases (1992-2001) and long-term management with low-dose aspirin in 24 cases. J Vet Intern Med 2003 17 (1) : 73 83.
230. Boudreaux MK, Dillon AR, Ravis WR, et al. Effects of treatment with aspirin or aspirin/dipyridamole combination in heartworm-negative, heartworm-infected, and embolized heartworm infected dogs. Am J Vet Res 1991 52 (12) : 1992 1999.
231. Tarish JH, Atwell RB. The effect of prostaglandin inhibition on the development of pulmonary pathology associated with dead Dirofilaria immitis. Vet Parasitol 1993 49 (2-4) : 207 217.
232. 2005 guidelines for the diagnosis, prevention and management of heartworm (Dirofilaria immitis) infection in dogs. American Heartworm Society Available at : Accessed 10-08-08.
233. Grauer GF. CVT update: canine glomerulonephritis, In : Bonagura JD. ed. Kirk's Current Veterinary Therapy XIII. Philadelphia : WB Saunders Co 2000, pp. 851 853.
234. Born G, Patrono C. Antiplatelet drugs. Br J Pharmacol 2006 147 (suppl 1) : S241 S251.
235. Patrono C, Coller B, Fitzgerald GA, et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004 126 (3, suppl) : 234S 264S.
236. Hogan DF, Andrews DA, Green HW, et al. Antiplatelet effects and pharmacodynamics of clopidogrel in cats. J Am Vet Med Assoc 2004 225 (9) : 1406 1411.
237. Accessed 10-08-08.
238. DeFranscesco R. Refractory heart failure. Proceedings IVECCS, San Antonio, TX, 2006.
239. Ware WA. Cardiovascular Disease in Small Animal Medicine, 1st ed. London : Manson Publishing 2007, p. 172.
240. Ramsey I. BSAVA Formulary, 6th ed. Quedgeley : BSAVA Publishing 2008, pp. 14 15.
241. Macintire DK, Drobatz KJ, Haskins SC, et al. Manual of Small Animal Emergency and Critical Care Medicine, 1st ed. Philadelphia : Lippincott, Williams & Wilkins 2005, p. 439.
242. Macintire DK, Drobatz KJ, Haskins SC, et al. Manual of Small Animal Emergency and Critical Care Medicine, 1st ed. Philadelphia : Lippincott, Williams & Wilkins 2005, p. 456.
243. Smith SA, Lewis DC, Kellerman DL. Adjustment of intermittent subcutaneous heparin therapy based on chromogenic heparin assay in 9 cats with thromboembolic disease. J Vet Intern Med 1998 12 : 200.
244. Kellerman DL, Lewis DC, Bruyette DS, et al. Determination and monitoring of a therapeutic heparin dosage in the dog. J Vet Intern Med 1995 9 : 187.